Network origin in Sara Pellegrino first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sara Pellegrino via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing | |
Telios Pharmaceuticals, Inc.
 Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Integra LifeSciences Holdings Corp., Telios Pharmaceuticals, Inc. is a pharmaceutical company focused on research. The company is based in San Diego, CA. The company was founded by Iain David Dukes, Erkki Ruoslahti. Telios Pharmaceuticals was acquired by Integra LifeSciences Holdings Corp. on August 17, 1995 for $35 million. | Pharmaceuticals: Major | Founder | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| TRAWS PHARMA, INC. | Biotechnology | Chairman | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Sales & Marketing | |
| University of Bath | College/University | Undergraduate Degree | |
| University of Otago | College/University | Undergraduate Degree | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Quogue Capital LLC
 Quogue Capital LLC Investment ManagersFinance Quogue Capital LLC (Quogue Capital) is a private equity firm founded in 2002 by Wayne P. Rothbaum. The firm is headquartered in New York. | Investment Managers | Founder | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| The University of Chicago | College/University | Masters Business Admin | |
| Temple University (Pennsylvania) | College/University | Doctorate Degree | |
| US Military Academy | College/University | Undergraduate Degree | |
| Santa Clara University | College/University | Undergraduate Degree Masters Business Admin | |
| Ursinus College | College/University | Undergraduate Degree | |
| University of Hamburg | College/University | Doctorate Degree | |
| Moscow Institute of Physics & Technology | College/University | Undergraduate Degree | |
| Université Paris Dauphine-PSL | College/University | Undergraduate Degree | |
| Massey University | College/University | Graduate Degree | |
| ESSEC Business School | College/University | Masters Business Admin | |
| The United States Army (District of Columbia) | Sovereign | Corporate Officer/Principal | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree | |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Androclus Therapeutics, Inc. | Chief Executive Officer | ||
| Universidad Autónoma de Ciudad Juárez | College/University | Doctorate Degree | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
BITOECH Consulting SAS
 BITOECH Consulting SAS Miscellaneous Commercial ServicesCommercial Services Part of Mabion SA, Biotech Consulting is a French company that provides business consulting services. The company is based in Cornier, France. | Miscellaneous Commercial Services | President | |
| IGNYTA INC | Biotechnology | Corporate Officer/Principal | |
| UC Davis School of Law | College/University | Undergraduate Degree | |
| GRITSTONE BIO, INC. | Biotechnology | Director of Finance/CFO | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Angiex, Inc.
 Angiex, Inc. Miscellaneous Commercial ServicesCommercial Services Angiex, Inc. operates as a biotechnology company, which engages in the development of an antibody-drug conjugate therapy for cancer. It focuses on TM4SF1, a membrane glycoprotein of tetraspanin topology that was originally discovered as a protein expressed on many human epithelial tumor cells. The company was founded by Paul Jaminet, Harold Dvorak, and Shou-Ching Jaminet in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Arrys Therapeutics, Inc.
 Arrys Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Part of Ikena Oncology, Inc., Arrys Therapeutics, Inc. provides treatments to cancer patients. The company is based in Boston, MA. The CEO of the company is Iain David Dukes. | Hospital/Nursing Management | Chief Executive Officer | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Founder Founder | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Viriom, Inc.
 Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market. | Miscellaneous Commercial Services | Chief Executive Officer | |
NeRRe Therapeutics Holdings Ltd.
 NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Miscellaneous Commercial Services | Director/Board Member | |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member | |
Trawsfynydd Therapeutics, Inc.
 Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trawsfynydd Therapeutics, Inc. engages in discovering and developing antiviral medicines. The company is located in the US. | Miscellaneous Commercial Services | Founder | |
Eilean Therapeutics LLC
 Eilean Therapeutics LLC Pharmaceuticals: MajorHealth Technology Eilean Therapeutics LLC is a biopharmaceutical company based in Dover, DE. Eilean Therapeutics is focused on the discovery and development of first-in-class small molecule inhibitors that target escape mutations in hematologic and solid cancers. Eilean Therapeutics LLC is utilizing a proprietary hybrid AI platform to accelerate the execution of discovery and development of novel breakthrough medicines to maximize the clinical benefit when treating hematologic and solid malignancies. The company was founded in 2022 by John C. Byrd and is co-founded by OrbiMed, Torrey Pines Investment. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| United States | 38 |
| France | 5 |
| United Kingdom | 3 |
| New Zealand | 3 |
| Switzerland | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 16 |
| Commercial Services | 7 |
| Finance | 3 |
| Technology Services | 2 |
Operational
| Director/Board Member | 46 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 21 |
| Chairman | 14 |
| Undergraduate Degree | 13 |
Most connected contacts
| Insiders | |
|---|---|
| Iain Dukes | 30 |
| Michael Weiser | 26 |
| Wendy Yarno | 19 |
| Athena Countouriotis | 17 |
| Igor Bilinsky | 11 |
| Ryan Maynard | 10 |
| Jim Ziegler | 9 |
| Wayne P. Rothbaum | 7 |
| Jean-Marc Bellemin | 6 |
| Frederick Vogt | 4 |
| Brian Shew | 4 |
| Tracy Winton | 4 |
| Friedrich Finckenstein | 3 |
| Raj K. Puri | 2 |
| Jen Saunders | 1 |
- Stock Market
- Insiders
- Sara Pellegrino
- Company connections
